Subungal abcesses secondary to paclitaxel

Dermatology Online Journal

Volumn 9, Issue 3, 2003, Pages 155-157

  Albares, M Pilar ^a   Belinchón, Isabel ^a   Pascual, Jose Carlos ^a   Vergara, Gloria ^a   Blanes, Mar ^a   Betlloch, Isabel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; PACLITAXEL;

ADULT; ARTICLE; BACTERIUM CULTURE; BREAST CANCER; CANDIDA ALBICANS; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MICROBIOLOGY; MYCOSIS; ONYCHOLYSIS; PARONYCHIA; PSEUDOMONAS AERUGINOSA; SKIN ABSCESS; SUBUNGAL ABCESS; TREATMENT OUTCOME; TUMOR GROWTH;

EID: 3042803298     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Vanhooteghem O, Richert B, Vindevoghel et al. Subungal abscess: a new ungal side-effect related to decetaxel therapy. Br J Dermatol 2000; 143: 445-473.
2. Flory SM, Solimando DA, Webster GF et al. Onycholysis associated with weekly administration of paclitaxel. Ann Pharmacother, 1999; 33: 584-586.
3. Correia O, Azevedo C, Pinto-Ferreira E et al. Nail changes secondary to docetaxel(Taxotere). Dermatology 1999; 198: 288-290.
4. Wantzin GL, Thomsen K. Acute paronychia after high-dose methrotexate therapy. Arch Dermatol 1983; 119: 623-624.